Diabetes Board decisions

The Veteran's claim for an effective date prior to October 5, 2014 for the grant of a 100 percent disability rating for CAD was denied.,The Veteran's claim for an effective date prior to January 31, 2012 for the grant of service connection for DMII was also denied.

The Board has granted the Veteran's claim for service connection for erectile dysfunction as secondary to his service-connected diabetes mellitus, Type II.

The Veteran's service connection claims for Parkinson's disease, diabetes mellitus, type II, prostate cancer, and hypertension are granted on a presumptive basis due to herbicide agent exposure during active service. The claim for service connection for stroke is remanded.

The Board has denied the Veteran's claims for service connection for prostate cancer and diabetes mellitus type II. The claim for service connection for obstructive sleep apnea is remanded.

The Veteran's appeal for backpay from the grant of service connection for diabetes mellitus, type II, in a June 2025 rating decision is dismissed as his October 2025 Notice of Disagreement did not identify an actual decision that addressed the claim.

The Veteran's claims for service connection for diabetes mellitus type II, erectile dysfunction, and a sleep disorder (narcolepsy) are dismissed. The claim for SMC based on aid and attendance is granted with an effective date of April 2, 2024. The Board has remanded the issue of service connection for a sleep disorder (narcolepsy).

The Veteran's initial 40 percent rating for hypertensive chronic kidney disease is granted, effective December 1, 2025. A TDIU is also granted.

The Veteran requested to withdraw his appeals for service connection for insomnia, an increased rating for diabetes mellitus type II, and a compensable rating for erectile dysfunction. The Board has dismissed these appeals.

The Board has denied service connection for diabetes mellitus type II, bilateral lower and upper extremity diabetic peripheral neuropathies, cardiovascular disease (including ischemic heart disease with myocardial infarction), and hypertension. The evidence does not establish herbicide agent exposure during the Veteran's service in Korea on a presumptive basis or based on direct evidence.

The Veteran's tinnitus claim is denied as he does not have a current disability.,The Veteran's prostate cancer claim is denied due to lack of exposure to contaminated water at Camp Lejeune and insufficient evidence linking his condition to service.,The Veteran's left ankle disability claim is remanded for further examination and opinion regarding pre-existing versus in-service aggravation.,The Veteran's lower back disability claim is remanded for a VA examination and medical opinion on the relationship between his current condition and service.,The Veteran's depression claim is remanded for a VA examination and medical opinion on the relationship between his current condition and service.,The Veteran's bilateral hearing loss claim is remanded for a new VA examination to determine if he has hearing loss and whether it is related to service.,The Veteran's type 2 diabetes mellitus, sleep apnea, and nontoxic goiter claims are remanded for further examination and opinion regarding their relationship to his left ankle injury.,The Veteran's sleep apnea claim is remanded for a VA examination and medical opinion on the relationship between his current condition and service.,The Veteran's nontoxic goiter claim is remanded for a VA examination and medical opinion on the relationship between his current condition and service.

The Veteran's claim for service connection for type 2 diabetes was granted with an effective date of October 17, 2018. The Board found sufficient evidence to support the grant on a facts-found basis and did not consider the PACT Act in this decision.

The Board has granted service connection for diabetes mellitus, type II due to herbicide exposure. The claim of service connection for an acquired psychiatric disorder is remanded as there are multiple pre-decisional duty to assist errors and the Veteran's small cell lung cancer may be related.

The Veteran's service connection claims for diabetes mellitus and MRSA are granted, with diabetes mellitus being granted under the PACT Act due to presumed exposure to herbicide agents in Cambodia. The claim for MRSA is remanded for further examination.

The Board has denied earlier effective dates for the awards of service connection for right ear hearing loss and tinnitus, finding that no new and material evidence was submitted within one year of the April 2004 rating decision denying these claims.,The Veteran's claim for diabetes mellitus is remanded due to a need for an addendum opinion addressing the relationship between his current disability and service.

The Veteran's appeal for service connection for diabetes mellitus has been dismissed due to an improper concurrent election of review options.

The Veteran's service-connected disabilities have caused him to need regular aid and attendance, leading to a grant of SMC based on the need for aid and attendance. The issue of entitlement to SMC at the housebound rate is dismissed as moot.

The Board granted an effective date of October 25, 2018, for the grant of service connection for bilateral lower extremity cellulitis secondary to service-connected DM. The Veteran also received a 30 percent rating for this condition as of October 11, 2022.

The Veteran's service-connected disabilities do not meet the criteria for special home adaptation as defined by VA regulations.

The Board has determined that new and relevant evidence has been received, warranting readjudication of the claims for service connection for Type II Diabetes Mellitus and Hypertension.

The Veteran's claims for service connection have been remanded due to insufficient evidence and need further evaluation.